Cargando…

CAR-T Cell Therapy in the Treatment of Pediatric Non-Hodgkin Lymphoma

Non-Hodgkin lymphomas (NHL) are a group of cancers that originate in the lymphatic system, especially from progenitor or mature B-cells, T-cells, or natural killer (NK) cells. NHL is the most common hematological malignancy worldwide and also the fourth most frequent type of cancer among pediatric p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ostojska, Magdalena, Nowak, Emilia, Twardowska, Julia, Lejman, Monika, Zawitkowska, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672004/ https://www.ncbi.nlm.nih.gov/pubmed/38003910 http://dx.doi.org/10.3390/jpm13111595

Ejemplares similares

The New Treatment Methods for Non-Hodgkin Lymphoma in Pediatric Patients
por: Derebas, Justyna, et al.
Publicado: (2022)

Molecular-Targeted Therapy of Pediatric Acute Myeloid Leukemia
por: Obszański, Piotr, et al.
Publicado: (2022)

CAR T-Cell Therapy in Children with Solid Tumors
por: Kulczycka, Marika, et al.
Publicado: (2023)

CAR-T Cells Immunotherapies for the Treatment of Acute Myeloid Leukemia—Recent Advances
por: Zarychta, Julia, et al.
Publicado: (2023)

Severe complications in the induction phase of therapy in a pediatric patient with T-cell acute lymphoblastic leukemia: A case report
por: Rocka, Agata, et al.
Publicado: (2023)

Editorial: Diagnosis and therapy pediatric hematological malignancies: recent progress
por: Zawitkowska, Joanna, et al.
Publicado: (2023)

Targeted Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia—Therapy and Toxicity Mechanisms
por: Lejman, Monika, et al.
Publicado: (2021)

Genomic Analyses of Pediatric Acute Lymphoblastic Leukemia Ph+ and Ph-Like—Recent Progress in Treatment
por: Kaczmarska, Agnieszka, et al.
Publicado: (2021)

Hypodiploidy in a pediatric patient of T-cell acute lymphoblastic leukemia: a case report
por: Stefaniak, Martyna, et al.
Publicado: (2021)

CAR-T Cell Therapy for Classical Hodgkin Lymphoma
por: Katsin, Mikalai, et al.
Publicado: (2023)

Updates in KMT2A Gene Rearrangement in Pediatric Acute Lymphoblastic Leukemia
por: Górecki, Mateusz, et al.
Publicado: (2023)

The New Therapeutic Strategies in Pediatric T-Cell Acute Lymphoblastic Leukemia
por: Lato, Marta Weronika, et al.
Publicado: (2021)

Overcoming Steroid Resistance in Pediatric Acute Lymphoblastic Leukemia—The State-of-the-Art Knowledge and Future Prospects
por: Kośmider, Kamil, et al.
Publicado: (2022)

Electrochemical and Optical Sensors for the Detection of Chemical Carcinogens Causing Leukemia
por: Kowalczyk, Adrian, et al.
Publicado: (2023)

Neurotoxicity Associated with Treatment of Acute Lymphoblastic Leukemia Chemotherapy and Immunotherapy
por: Śliwa-Tytko, Patrycja, et al.
Publicado: (2022)

Overview on Aneuploidy in Childhood B-Cell Acute Lymphoblastic Leukemia
por: Panuciak, Kinga, et al.
Publicado: (2023)

Comprehensive Overview of Gene Rearrangements in Childhood T-Cell Acute Lymphoblastic Leukaemia
por: Mroczek, Anna, et al.
Publicado: (2021)

Targeted Therapies for the Treatment of Pediatric Non-Hodgkin Lymphomas: Present and Future
por: Sorge, Caryn E., et al.
Publicado: (2016)

Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma
por: Jackson, Zachary, et al.
Publicado: (2020)

The Emerging Role of CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma
por: Meier, Jeremy A., et al.
Publicado: (2022)

First-line treatment failure in childhood acute lymphoblastic leukemia: The polish pediatric leukemia and lymphoma study group experience
por: Zawitkowska, Joanna, et al.
Publicado: (2020)

Prophylactic Tocilizumab Prior to Anti-CD19 CAR-T Cell Therapy for Non-Hodgkin Lymphoma
por: Caimi, Paolo F., et al.
Publicado: (2021)

The Use of Inhibitors of Tyrosine Kinase in Paediatric Haemato-Oncology—When and Why?
por: Kaczmarska, Agnieszka, et al.
Publicado: (2021)

Comprehensive chromosomal aberrations in a case of a patient with TCF3-HLF-positive BCP-ALL
por: Lejman, Monika, et al.
Publicado: (2020)

The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma
por: Wei, Jianshu, et al.
Publicado: (2020)

The Role of TRL7/8 Agonists in Cancer Therapy, with Special Emphasis on Hematologic Malignancies
por: Leśniak, Maria, et al.
Publicado: (2023)

Recent Advances in Treatment Options for Childhood Acute Lymphoblastic Leukemia
por: Malczewska, Marta, et al.
Publicado: (2022)

Case report: simultaneous occurrence of multiple myeloma and non-Hodgkin lymphoma treated by CAR T therapy
por: Li, Tongjuan, et al.
Publicado: (2020)

Response to COVID-19 Vaccination Post-CAR T Therapy in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma
por: Wiedmeier-Nutor, Julia Erin, et al.
Publicado: (2022)

Diagnostic difficulties of AH1N1 influenza infection in children with acute lymphoblastic leukemia: Two case reports
por: Zawitkowska, Joanna, et al.
Publicado: (2020)

A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions
por: Marofi, Faroogh, et al.
Publicado: (2021)

Response to COVID-19 Vaccination Post-CAR T Therapy in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma
por: Wiedmeier, Julia E., et al.
Publicado: (2021)

Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma
por: Wiedmeier-Nutor, Julia E., et al.
Publicado: (2023)

Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
por: Chang, Sun Hee, et al.
Publicado: (2015)

Ultrasound presentation of abdominal non-Hodgkin lymphomas in pediatric patients
por: Brodzisz, Agnieszka, et al.
Publicado: (2013)

Genetic Disorders with Predisposition to Paediatric Haematopoietic Malignancies—A Review
por: Filipiuk, Aleksandra, et al.
Publicado: (2022)

Ibrutinib improves the efficacy of anti‐CD19‐CAR T‐cell therapy in patients with refractory non‐Hodgkin lymphoma
por: Liu, Meijing, et al.
Publicado: (2021)

Retraction: A deep insight into CAR-T cell therapy in non-Hodgkin lymphoma: application, opportunities, and future directions
Publicado: (2023)

Consolidative radiotherapy for residual fluorodeoxyglucose activity on day +30 post CAR T-cell therapy in non-Hodgkin lymphoma
por: Saifi, Omran, et al.
Publicado: (2023)

Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience
por: Casadei, Beatrice, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9c36tqq7mmritfg4p5qqi9ubf1